Tunnel vision or global outlook? Global Pharma's preoccupation with the US.
COVID-19 is a litmus test of whether health systems can pool assets and expertise and fairly distribute resources so that patients worldwide can benefit equally, writes Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation.